MSD
For over 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of their mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A.
See below for the Latest MSD News, Analysis, Profit Results, Share Price Information, and Commentary.
MSD navigates the pandemic tapestry in COVID-19 fight
MSD navigates the pandemic tapestry in COVID-19 fight
It has navigated the complexities of the challenging period through a proactive approach.
Join the community
Most Read
1. Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034 2. Asian medical device markets face cost shocks amidst Iran conflict 3. Global dental articulators market to reach $227.8m by 2030 4. Neurological disorders and aging boost brain-computer interface market 5. AJJ Medtech hits $8m order book with $3m green supply dealResource Center
Events
Event News
Co-Written / Partner
Pureland Venture’s Chris Hardesty: Governments must sustain long-term focus on healthcare innovation, technology
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation